Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Another issue counsel addressed was the effect of a broadening reissue, which he was careful to emphasize (again) was not the case here (nor does Merck advocate for PTE under such circumstances).

Now there’s a new one for the list: cancer prevention vaccines. Merck, which makes the commonly used Gardasil shot, has shed 14 per cent of its market value since announcing last week that it ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Cuscaden Peak Investments—backed by Singapore state-linked investor Temasek Holdings—is seeking to take Paragon REIT private ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

StockNews.com upgraded shares of Petco Health and Wellness (NASDAQ:WOOF – Free Report) from a hold rating to a buy rating in a research note published on Saturday. Several other research analysts also ...

Singapore's Temasek-backed sponsor of Paragon REIT offered to take the retail investment trust private, valuing it at more than $2 billion, in a bid to renovate its flagship shopping mall in the heart ...

Shares of TriCo Bancshares (NASDAQ:TCBK – Get Free Report) have received a consensus rating of “Hold” from the five analysts that are currently covering the firm, Marketbeat reports. Three equities ...